Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of One Kind of Controllable Tube Ileostomy to Protect Anastomotic Leakage in the Low Rectal Cancer.

NCT02012023 is registered in ClinicalTrials.gov with First Affiliated Hospital of Zhejiang University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02012023 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of One Kind of Controllable Tube Ileostomy to Protect Anastomotic Leakage in the Low Rectal Cancer.
Lead sponsor
First Affiliated Hospital of Zhejiang University
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2014
Completion date
August 31, 2016
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

low anterior resection, rectal neoplasms